Senti Bio Highlights Preclinical Data from Multiple Gene Circuit Enabled Cell Therapy Programs at Annual AACR Meeting
– Preclinical data supports SENTI-202 as a potential first-in-class logic gated CAR-NK cell therapy; remains on track for IND submission in 2H 2023 – – Additional data... | April 17, 2023
United States Tim Lu Kelli Perkins Exchange Commission Clinical Research Excluding Trials Senti Biosciences Inc
Source: marketscreener.com